Dyadic International Inc (DYAI) - Total Assets
Based on the latest financial reports, Dyadic International Inc (DYAI) holds total assets worth $11.67 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Dyadic International Inc for net asset value and shareholders' equity analysis.
Dyadic International Inc - Total Assets Trend (2003–2024)
This chart illustrates how Dyadic International Inc's total assets have evolved over time, based on quarterly financial data.
Dyadic International Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Dyadic International Inc's total assets of $11.67 Million consist of 99.0% current assets and 1.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 65.5% |
| Accounts Receivable | $237.03K | 2.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Dyadic International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Dyadic International Inc (DYAI) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dyadic International Inc's current assets represent 99.0% of total assets in 2024, a decrease from 100.0% in 2003.
- Cash Position: Cash and equivalents constituted 65.5% of total assets in 2024, down from 76.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 7207.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 2.4% of total assets.
Dyadic International Inc Competitors by Total Assets
Key competitors of Dyadic International Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Dyadic International Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.85 | 5.15 | 18.32 |
| Quick Ratio | 2.85 | 5.15 | 18.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $7.49 Million | $8.61 Million | $28.16 Million |
Dyadic International Inc - Advanced Valuation Insights
This section examines the relationship between Dyadic International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.52 |
| Latest Market Cap to Assets Ratio | 2.88 |
| Asset Growth Rate (YoY) | 20.8% |
| Total Assets | $9.93 Million |
| Market Capitalization | $28.59 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Dyadic International Inc's assets at a significant premium (2.88x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Dyadic International Inc's assets grew by 20.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dyadic International Inc (2003–2024)
The table below shows the annual total assets of Dyadic International Inc from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.93 Million | +20.82% |
| 2023-12-31 | $8.22 Million | -40.06% |
| 2022-12-31 | $13.71 Million | -35.62% |
| 2021-12-31 | $21.30 Million | -29.17% |
| 2020-12-31 | $30.07 Million | -19.71% |
| 2019-12-31 | $37.45 Million | -13.51% |
| 2018-12-31 | $43.30 Million | -14.67% |
| 2017-12-31 | $50.74 Million | -13.55% |
| 2016-12-31 | $58.70 Million | -23.43% |
| 2015-12-31 | $76.67 Million | +798.23% |
| 2014-12-31 | $8.54 Million | -42.87% |
| 2013-12-31 | $14.94 Million | +15.99% |
| 2012-12-31 | $12.88 Million | +25.06% |
| 2011-12-31 | $10.30 Million | +0.68% |
| 2010-12-31 | $10.23 Million | -28.76% |
| 2009-12-31 | $14.36 Million | +37.68% |
| 2008-12-31 | $10.43 Million | -60.02% |
| 2007-12-31 | $26.09 Million | -42.20% |
| 2006-12-31 | $45.14 Million | +90.03% |
| 2005-12-31 | $23.75 Million | -27.41% |
| 2004-12-31 | $32.72 Million | +198422.27% |
| 2003-12-31 | $16.48K | -- |
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and la… Read more